Lin Liu1,2, Shu-Yu Ni1,2, Wei Yan3, Qing-Dong Lu1,2, Yi-Miao Zhao1,2, Ying-Ying Xu1,2, Huan Mei1,2, Le Shi3, Kai Yuan3, Ying Han1, Jia-Hui Deng3, Yan-Kun Sun3, Shi-Qiu Meng1, Zheng-Dong Jiang4, Na Zeng1,2,5, Jian-Yu Que3, Yong-Bo Zheng3, Bei-Ni Yang1,2, Yi-Miao Gong3, Arun V Ravindran6, Thomas Kosten7, Yun Kwok Wing8, Xiang-Dong Tang9, Jun-Liang Yuan3, Ping Wu1, Jie Shi1, Yan-Ping Bao1,2, Lin Lu1,3,10. 1. National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China. 2. School of Public Health, Peking University, Beijing, China. 3. Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Chinese Academy of Medical Sciences Research Unit (No. 2018RU006), Peking University, Beijing 100191, China. 4. Wuhan Wuchang Hospital, Wuhan University of Science and Technology, Wuhan, China. 5. Beijing Friendship Hospital, Capital Medical University, Beijing, China. 6. Department of Psychiatry, University of Toronto, Toronto, Canada. 7. Department of Psychiatry, Baylor College of Medicine, Houston, TX, United States. 8. Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China. 9. Sleep Medicine Center, Department of Respiratory and Critical Care Medicine, Mental Health Center and Translational Neuroscience Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. 10. Peking-Tsinghua Centre for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing, China.
Abstract
BACKGROUND: Coronavirus disease 2019 (COVID-19) has evolved into a worldwide pandemic, and has been found to be closely associated with mental and neurological disorders. We aimed to comprehensively quantify the association between mental and neurological disorders, both pre-existing and subsequent, and the risk of susceptibility, severity and mortality of COVID-19. METHODS: In this systematic review and meta-analysis, we searched PubMed, Web of Science, Embase, PsycINFO, and Cochrane library databases for studies published from the inception up to January 16, 2021 and updated at July 7, 2021. Observational studies including cohort and case-control, cross-sectional studies and case series that reported risk estimates of the association between mental or neurological disorders and COVID-19 susceptibility, illness severity and mortality were included. Two researchers independently extracted data and conducted the quality assessment. Based on I2 heterogeneity, we used a random effects model to calculate pooled odds ratios (OR) and 95% confidence intervals (95% CI). Subgroup analyses and meta-regression analysis were also performed. This study was registered on PROSPERO (registration number: CRD 42021230832). FINDING: A total of 149 studies (227,351,954 participants, 89,235,737 COVID-19 patients) were included in this analysis, in which 27 reported morbidity (132,727,798), 56 reported illness severity (83,097,968) and 115 reported mortality (88,878,662). Overall, mental and neurological disorders were associated with a significant high risk of infection (pre-existing mental: OR 1·67, 95% CI 1·12-2·49; and pre-existing neurological: 2·05, 1·58-2·67), illness severity (mental: pre-existing, 1·40, 1·25-1·57; sequelae, 4·85, 2·53-9·32; neurological: pre-existing, 1·43, 1·09-1·88; sequelae, 2·17, 1·45-3·24), and mortality (mental: pre-existing, 1·47, 1·26-1·72; neurological: pre-existing, 2·08, 1·61-2·69; sequelae, 2·03, 1·66-2·49) from COVID-19. Subgroup analysis revealed that association with illness severity was stronger among younger COVID-19 patients, and those with subsequent mental disorders, living in low- and middle-income regions. Younger patients with mental and neurological disorders were associated with higher mortality than elders. For type-specific mental disorders, susceptibility to contracting COVID-19 was associated with pre-existing mood disorders, anxiety, and attention-deficit hyperactivity disorder (ADHD); illness severity was associated with both pre-existing and subsequent mood disorders as well as sleep disturbance; and mortality was associated with pre-existing schizophrenia. For neurological disorders, susceptibility was associated with pre-existing dementia; both severity and mortality were associated with subsequent delirium and altered mental status; besides, mortality was associated with pre-existing and subsequent dementia and multiple specific neurological diseases. Heterogeneities were substantial across studies in most analysis. INTERPRETATION: The findings show an important role of mental and neurological disorders in the context of COVID-19 and provide clues and directions for identifying and protecting vulnerable populations in the pandemic. Early detection and intervention for neurological and mental disorders are urgently needed to control morbidity and mortality induced by the COVID-19 pandemic. However, there was substantial heterogeneity among the included studies, and the results should be interpreted with caution. More studies are needed to explore long-term mental and neurological sequela, as well as the underlying brain mechanisms for the sake of elucidating the causal pathways for these associations. FUNDING: This study is supported by grants from the National Key Research and Development Program of China, the National Natural Science Foundation of China, Special Research Fund of PKUHSC for Prevention and Control of COVID-19, and the Fundamental Research Funds for the Central Universities.
BACKGROUND: Coronavirus disease 2019 (COVID-19) has evolved into a worldwide pandemic, and has been found to be closely associated with mental and neurological disorders. We aimed to comprehensively quantify the association between mental and neurological disorders, both pre-existing and subsequent, and the risk of susceptibility, severity and mortality of COVID-19. METHODS: In this systematic review and meta-analysis, we searched PubMed, Web of Science, Embase, PsycINFO, and Cochrane library databases for studies published from the inception up to January 16, 2021 and updated at July 7, 2021. Observational studies including cohort and case-control, cross-sectional studies and case series that reported risk estimates of the association between mental or neurological disorders and COVID-19 susceptibility, illness severity and mortality were included. Two researchers independently extracted data and conducted the quality assessment. Based on I2 heterogeneity, we used a random effects model to calculate pooled odds ratios (OR) and 95% confidence intervals (95% CI). Subgroup analyses and meta-regression analysis were also performed. This study was registered on PROSPERO (registration number: CRD 42021230832). FINDING: A total of 149 studies (227,351,954 participants, 89,235,737 COVID-19 patients) were included in this analysis, in which 27 reported morbidity (132,727,798), 56 reported illness severity (83,097,968) and 115 reported mortality (88,878,662). Overall, mental and neurological disorders were associated with a significant high risk of infection (pre-existing mental: OR 1·67, 95% CI 1·12-2·49; and pre-existing neurological: 2·05, 1·58-2·67), illness severity (mental: pre-existing, 1·40, 1·25-1·57; sequelae, 4·85, 2·53-9·32; neurological: pre-existing, 1·43, 1·09-1·88; sequelae, 2·17, 1·45-3·24), and mortality (mental: pre-existing, 1·47, 1·26-1·72; neurological: pre-existing, 2·08, 1·61-2·69; sequelae, 2·03, 1·66-2·49) from COVID-19. Subgroup analysis revealed that association with illness severity was stronger among younger COVID-19 patients, and those with subsequent mental disorders, living in low- and middle-income regions. Younger patients with mental and neurological disorders were associated with higher mortality than elders. For type-specific mental disorders, susceptibility to contracting COVID-19 was associated with pre-existing mood disorders, anxiety, and attention-deficit hyperactivity disorder (ADHD); illness severity was associated with both pre-existing and subsequent mood disorders as well as sleep disturbance; and mortality was associated with pre-existing schizophrenia. For neurological disorders, susceptibility was associated with pre-existing dementia; both severity and mortality were associated with subsequent delirium and altered mental status; besides, mortality was associated with pre-existing and subsequent dementia and multiple specific neurological diseases. Heterogeneities were substantial across studies in most analysis. INTERPRETATION: The findings show an important role of mental and neurological disorders in the context of COVID-19 and provide clues and directions for identifying and protecting vulnerable populations in the pandemic. Early detection and intervention for neurological and mental disorders are urgently needed to control morbidity and mortality induced by the COVID-19 pandemic. However, there was substantial heterogeneity among the included studies, and the results should be interpreted with caution. More studies are needed to explore long-term mental and neurological sequela, as well as the underlying brain mechanisms for the sake of elucidating the causal pathways for these associations. FUNDING: This study is supported by grants from the National Key Research and Development Program of China, the National Natural Science Foundation of China, Special Research Fund of PKUHSC for Prevention and Control of COVID-19, and the Fundamental Research Funds for the Central Universities.
Authors: Aline Mendes; Christine Serratrice; François R Herrmann; Laurence Genton; Samuel Périvier; Max Scheffler; Thomas Fassier; Philippe Huber; Marie-Claire Jacques; Virginie Prendki; Xavier Roux; Katharine Di Silvestro; Véronique Trombert; Stephan Harbarth; Gabriel Gold; Christophe E Graf; Dina Zekry Journal: J Am Med Dir Assoc Date: 2020-09-15 Impact factor: 4.669
Authors: Ahmad A Toubasi; Rand B AbuAnzeh; Hind B Abu Tawileh; Renad H Aldebei; Saif Aldeen S Alryalat Journal: Psychiatry Res Date: 2021-03-03 Impact factor: 11.225
Authors: X Goldberg; G Castaño-Vinyals; A Espinosa; A Carreras; L Liutsko; E Sicuri; M Foraster; C O'Callaghan-Gordo; P Dadvand; G Moncunill; C Dobaño; B Cortés; V Pleguezuelos; K Straif; J Garcia-Aymerich; R de Cid; E Cardis; M Kogevinas Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2022-05-28 Impact factor: 4.519
Authors: Konstantinos Dimitriadis; Jan Meis; Hermann Neugebauer; Kristian Barlinn; Bernhard Neumann; Georg Gahn; Piergiorgio Lochner; Benjamin Knier; Sarah Lindemann; Kurt Wolfram Sühs; Kristina Szabo; Thomas Pfefferkorn; Ingo Schirotzek; Tobias Freilinger; Bassa Burc; Albrecht Günther; Matthias Wittstock; Patrick Schramm; Gernot Reimann; Jana Godau; Gabor Nagy; Fatima B Koenig; Fabian Essig; Hartwig Klinker; Christian Hartmann; Moritz L Schmidbauer; Tim Steinberg; Lora Lefterova; Christina Klose; Julian Bösel Journal: Crit Care Date: 2022-07-16 Impact factor: 19.334
Authors: Marc De Hert; Victor Mazereel; Marc Stroobants; Livia De Picker; Kristof Van Assche; Johan Detraux Journal: Front Psychiatry Date: 2022-01-13 Impact factor: 4.157
Authors: Rene Marquez-Franco; Jose Damian Carrillo-Ruiz; Ana Luisa Velasco; Francisco Velasco Journal: Front Psychiatry Date: 2022-02-16 Impact factor: 4.157
Authors: Jonás Carmona-Pírez; Ignatios Ioakeim-Skoufa; Antonio Gimeno-Miguel; Beatriz Poblador-Plou; Francisca González-Rubio; Dolores Muñoyerro-Muñiz; Juliana Rodríguez-Herrera; Juan Antonio Goicoechea-Salazar; Alexandra Prados-Torres; Román Villegas-Portero Journal: Int J Environ Res Public Health Date: 2022-03-23 Impact factor: 3.390
Authors: Olaoluwa O Okusaga; Rachel L Kember; Gina M Peloso; Roseann E Peterson; Mariana Vujkovic; Brian G Mitchell; Jared Bernard; Annette Walder; Tim B Bigdeli Journal: Complex Psychiatry Date: 2021-12-01